Fund HoldingsDarwin Global Management, Ltd.

Total Portfolio Value
$751.17M
Total Bought
$668.34M
Total Sold
$426.65M
Net Transaction
+$241.68M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
VAXCYTE INC(PCVX)579,9592,750,804+2,170,84536,421187,90725.02%+151,486
NUVALENT INC(NUVL)57,6981,436,964+1,379,2664,246107,90214.36%+103,656
BIOHAVEN LTD(BHVN)01,476,974+1,476,974080,77610.75%+80,776
ALPINE IMMUNE SCIENCES INC01,982,016+1,982,016078,56710.46%+78,567
BEAM THERAPEUTICS INC(BEAM)02,119,598+2,119,598070,0329.32%+70,032
APOGEE THERAPEUTICS INC(APGE)0832,198+832,198055,3007.36%+55,300
KEROS THERAPEUTICS INC1,060,4271,435,950+375,52342,16395,06012.65%+52,897
XENCOR INC(XNCR)01,109,650+1,109,650024,5573.27%+24,557
SPYRE THERAPEUTICS INC(SYRE)0473,200+473,200017,9482.39%+17,948
ELEVATION ONCOLOGY INC02,332,928+2,332,928011,9681.59%+11,968
TOURMALINE BIO INC0465,000+465,000010,6491.42%+10,649
MERCK & CO INC(MRK)079,600+79,600010,5031.40%+10,503
SPRINGWORKS THERAPEUTICS INC192,7340-192,7347,0350-7,035
CYTOKINETICS INC(CYTK)600,0000-600,00050,0940-50,094
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)1,039,2890-1,039,28962,7630-62,763
TG THERAPEUTICS INC(TGTX)4,046,5980-4,046,59869,1160-69,116
AMBRX BIOPHARMA INC16,688,6360-16,688,636237,6460-237,646
Page 1 of 1